TODAY'S MARKET INTELLIGENCE
Guoyao Xiandai Plans to Acquire 51% of Guorui Pharma for RMB 406 Million
English summary
Guoyao Xiandai announced on August 19, 2026, that it plans to acquire 51% equity of Guorui Pharma for RMB 406 million. The acquisition is expected to expand its pharmaceutical footprint.
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence